In various cancers, including ovarian, testicular, endocervical, liver, and lung adenocarcinoma, CLDN7 is highly expressed and activates multiple signaling pathways involved in tumor growth, migration, invasion, and chemo-resistance [67]. Here, CLDN7 is linked to cancer.